Dr Snehlata Kumari understands the role of NF-kB signalling in regulating skin inflammation. Dr Kumari made fundamental discoveries in identifying essential roles of NF-kB, cytokines, and apoptosis and necroptosis signalling pathways in regulating skin homeostasis and inflammation. These findings advanced the knowledge of skin immunity, and opened up new avenues for novel potential targets in skin inflammation. At the forefront of skin immunity research, these findings were published in leading journals such as Nature and Immunity.
Dr Kumari's contributions received recognition from global scientific communities including the German National Academy of Sciences- Leopoldina, International Investigative Dermatology and European Society for Dermatological Research. She was awarded a career development grant on melanoma research from the German Research Foundation-SFB 829. She is the winner of 2021 Christina Fleischmann award to young women investigators from the Ineternational Cytokine and Interferon Society.
Dr Kumari is Research Leader at The University of Queensland Diamantina Institute. Her laboratory currently focuses on identifying and understanding immuno-modulatory mechanisms controlling inflammatory skin diseases and skin cancer.